Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp YouTube

Caroline Chen

Reporter

Caroline Chen covers health care for ProPublica. Previously, she worked at Bloomberg News, where she wrote about Valeant Pharmaceutical’s use of a mail order pharmacy to boost reimbursements for its drugs, the tactics used by a rare disease drugmaker to scare patients into staying on therapy, and the plight of medically complex babies who get stranded in hospitals because of a lack of home-care nurses. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.

Black Patients Miss Out On Promising Cancer Drugs

A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them.

A Cancer Patient’s Guide to Clinical Trials

If you’re considering whether to enroll in a trial of an experimental drug, here’s what you need to know.

Have You Donated or Helped to Collect Birth Tissue?

ProPublica is seeking your help in finding out how birth tissue donated by mothers is used in research and by industry.

Immigrant Shelters Drug Traumatized Teenagers Without Consent

Whether they came to the U.S. alone, or were forcibly separated from their families at the border, despondent minors are often pressured into taking psychotropic drugs without approval from a parent or guardian.

FDA Repays Industry by Rushing Risky Drugs to Market

As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.

Follow ProPublica

Latest Stories from ProPublica

Current site Current page